Ophthalmology Doctors in Orchard Park, NY Accepting Medicare

7 Ophthalmology doctors found. Showing 1 - 7

Mr. Mark Samuel Mandelcorn, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 301 Sterling Drive, Orchard Park, NY 14127 Phone: 716-677-6500    Fax: 716-677-6507

Michael Campbell, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3151 Southwestern Blvd, Orchard Park, NY 14127 Phone: 716-674-6030

Nathaniel Simmons, Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3151 Southwester Blvd, Orchard Park, NY 14127 Phone: 716-674-6030

Dr. Leonard Gurevich, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 301 Sterling Dr, Orchard Park, NY 14127 Phone: 716-677-6500    Fax: 716-677-6507

Deepan Selvadurai, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3055 Southwestern Blvd Ste 108, Orchard Park, NY 14127 Phone: 716-671-9020

Dr. Albert Schlisserman, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3151 Southwestern Blvd, Orchard Park, NY 14127 Phone: 716-674-6030    Fax: 716-674-6052

Dr. Malcolm C Mcisaac, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 205 Elmhurst Dr, Orchard Park, NY 14127 Phone: 716-662-4261

News Archive

Patient enrollment in three late-stage clinical trials completed

Inspire Pharmaceuticals, Inc. announced today patient enrollment is complete in three of its late-stage clinical trials.

FDA invites Amgen for ODAC meeting on XGEVA sBLA to treat castration-resistant prostate cancer

Amgen today announced the U.S. Food and Drug Administration has invited the Company to participate in a meeting of the Oncologic Drugs Advisory Committee (ODAC) on Feb. 8, 2012 to discuss the supplemental Biologics License Application (sBLA) for XGEVA (denosumab) to treat men with castration-resistant prostate cancer (CRPC) at high risk of developing bone metastases.

Specific plant oil may reduce belly fat in humans

Scientists have known for years that belly fat leads to serious medical problems, including diabetes, cardiovascular disease, hypertension and stroke. Now, a University of Missouri researcher has found a plant oil that may be able to reduce belly fat in humans.

EU and industry-funded project aims to personalize diabetes treatment

Diabetes is a chronic and incurable illness linked to blood sugar that has traditionally been divided into type 1 and type 2. Type 2 accounts for the vast majority of cases – some 285 million – and its prevalence is expected to soar over the coming decade.

Read more Medical News

› Verified 4 days ago